Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?

Journal of Endocrinological Investigation

Volumn 27, Issue 6, 2004, Pages 565-569

  Pohlink, C ^a   Tannapfel, A ^a   Eichfeld, U ^a   Schmidt, F ^a   Fuhrer D ^a   Paschke, R ^a   Koch, C A ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adrenal; Adrenocortical tumor; Tumor heterogeneity; Weiss criteria

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; MITOTANE;

ACUTE PYELONEPHRITIS; ADRENAL CORTEX ADENOMA; ADRENAL TUMOR; ADRENALECTOMY; ADULT; APOPTOSIS; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GENETIC HETEROGENEITY; HUMAN; LUNG METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR NECROSIS; ULTRASOUND;

EID: 4544345013     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347480     Document Type: Article

References (34)

1. Russi S, Blumenthal HT, Gray SH. Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Int Med 1945, 76: 284-96.
2. Hedeland H, Ostberg G, Hokfelt B. On the prevalence of adrenolcortical adenomas in an autopsy material in relation to hypertension and diabetes. Act Med Scand 1968, 194: 211-4.
3. Kloos RT, Gross MD, Francis IR, et al. Incidentally discovered adrenal masses. End Rev 1995, 16: 460-84.
4. National Cancer Institute, Biometrics branch. In: Cutler SJ, Young JL eds. Third national cancer survey: incidence data. National Cancer Institute Monograph. Washington: Government Printing Office. 1975, 41: 75-787
5. Wooten MD, King DK. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993, 72: 3145-55.
6. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Path 1984, 8: 163-9.
7. Giquel C, Bertagna X, Gaston V, et al. Molecular marker and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Canc Res 2001, 61: 6762-7.
8. Koch CA, Pacak K, Chrousos GP. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 2002, 87: 5367-84.
9. Abraham J, Bakke S, Rutt A, et al. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Cancer 2002, 94: 2333-43.
10. Korobkin M, Brodeur FJ, Francis IR, et al. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996, 200: 737-42.
11. National Institutes of Health. State-of-the-science-conference-statement. Managment of the Clinically Inapparent Adrenal Mass ("Incidentaloma"). Final statement 8/2002. http://consensus.nih.gov
12. Kopf D, Goretzki PE, Lehnert H. Clinical management of malignant adrenal tumors. J Canc Res Clin Oncol 2001, 127: 143-55.
13. Terzolo M, Boccuzzi A, Bovio S, Cappia S, et al. Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors. Urology 2001, 57: 176-82.
14. Dackiw AP, Lee JE, Gagel RF, Evans DB. Adrenal cortical carcinoma. World J Surg 2001, 25: 914-26.
15. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology. J Clin Endocrinol Metab 2000, 85: 637-44.
16. Barnett CC Jr, Varma DG, EI-Naggar AK, et al. Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 2000, 128: 973-82.
17. Tang CK, Gray GF. Adrenocortical neoplasms. Prognosis and morphology. Urology 1977, 5: 691-5.
18. Falke THM, te Strake L, Shaff MJ, et al. MR imaging of the adrenals: correlation with computed tomography. J Comput Assist Tomogr 1986, 10: 242-53.
19. Bernardino ME. Managment of the asymptomatic patient with unilateral adrenal mass. Radiology 1988, 166: 121-3.
20. Davis PL, Hricak H, Bradley WG Jr. Magnetic resonance imaging of the adrenal glands. Radiol Clin North Am 1984, 22: 891-5.
21. Van Erkel AR, van Gils APG, Lequin M, et al. CT and MR distinction of adenomas and nonadenomas of the adrenal glands. J Comput Assist Tomogr 1994, 18: 432-8.
22. McLoughlin RF, Bilbey JH. Tumors of the adrenal gland: findings on CT and MR imaging. Am J Roentgenol 1994, 163: 1413-8.
23. Reining JW, Doppman JL, Dwyer AJ, et al. MRI of indeterminate adrenal masses. AJR 1986, 147: 493-6.
24. Khafagi FA, Gross MD, Shapiro B, et al. Clinical significance of the large adrenal mass. Br J Surg 1991, 78: 828-33.
25. Siren JE, Haapiainen RK, Huikuri KT, et al. Incidentalomas of the adrenal gland: 36 operated patients and review of literature 1993, 17: 634-9.
26. Hussein S, Belldegrun A, Seltzer SE, et al. Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. AJR Am J Roentgenol 1985, 144: 61-5.
27. Paivansalo M, Lahde S, Merikanto J, et al. Computed tomography in primary and secondary adrenal tumours. Acta Radiol 1988, 29: 519-22.
28. Dominguez-Gadea L, Diez L, Bas C, et al. Differential diagnosis of solid adrenal masses using adrenocortical szintigraphy. Clin Radiol 1994, 49: 796-9.
29. Gross MD, Shapiro B, Francis IR, et al. Scintigraphic evaluation of clinically silent adrenal masses, J Nucl Med 1994, 35: 1145-52.
30. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991, 179: 415-8.
31. Gross MD, Shapiro B, Francis IR, et al. Incidentally discovered bilateral adrenal masses. Eur J Nucl Med 1995, 22: 315-21.
32. Lucon AM, Pereira MA, Mendonca BB, et al. Adrenocortical tumors: results of treatment and study of the Weiss score as a prognostic factor. Rev Hosp Clin Fac Med Sao Paulo 2002, 57: 251-6.
33. Terzolo M, Ali A, Osella G, Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 1997, 132: 914-9.
34. Stojadinovic A, Ghossein RA, Hoos A, et al. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 2002, 20: 941-50.